IR
Superintel
OverviewMarketsWatchlist
© 2026 IR SuperintelMethodologyContact

Marinus Pharmaceuticals Inc

CUSIP: 56854Q901 | 5 institutional holders

Quarters

Q2 2020Q1 2020Q4 2019Q3 2019Q2 2019
CompareDetailedHistoricalFundsOptions13D/13GPeersTargetingTrading SummaryProfile